Laboratorio Elea Phoenix
Pre-Approval PRO BETASlowing Activity
No new clinical trials started in 1-2 years. Monitor for changes in pipeline strategy. Last trial started: 11/28/2024
Pipeline by Phase
Therapeutic Focus
Clinical Trials (17)
Double-blind Study to Evaluate the PK, Efficacy, Safety and Immunogenicity of MB12 Versus Keytruda® in Stage IV NSCLC
Started: 8/15/2023
Shorter Benznidazole Regimens Compared to the Standard Regimen for Chagas Disease
Started: 7/28/2021
Clinical Trial to Evaluate the Efficacy, Immunogenicity and Safety of the Inactivated SARS-CoV-2 Vaccine (COVID-19)
Started: 9/16/2020
Safety and Clinical Effectiveness of Intravitreal Bevacizumab (Lumiere®) in Patients With Wet Age-related Macular Degeneration (Wet AMD)
Started: 2/7/2017
Clinical Trial with Cannabidiol (Kanbis®) for Parkinson Disease Symptoms
Started: 11/28/2024
Racotumomab in Patients With High-risk Neuroblastoma
Started: 11/1/2016
Ivermectin Effect on SARS-CoV-2 Replication in Patients With COVID-19
Started: 5/18/2020
Desmopressin (DDAVP) in Patients With Colorectal Cancer and Rectal Bleeding
Started: 4/1/2013
Concurrent Treatment of Squamous Cell Carcinoma or Adenocarcinoma of the Cervix With CIGB-300 for Local Application
Started: 5/1/2011
Perioperative Use of Desmopressin (DDAVP) in Breast Cancer
Started: 11/1/2011
Immunotherapy With Racotumomab Versus Support Treatment in Advanced Non-small Cell Lung Cancer Patients
Started: 9/1/2009
Bioequivalence Study of Two Formulations With the Association of Tenofovir 300 mg and Emtricitabine 200 mg.
Started: 9/1/2014
Use of Racotumomab in Patients With Pediatric Tumors Expressing N-glycolylated Gangliosides
Started: 2/1/2011
Bioequivalence Study of Two Extended Release Formulations Containing 50 mg of Quetiapine.
Started: 3/13/2017
Bioequivalence Study of Two Formulatiosns With the Asscociaton of Efavirenz, Emtricitabine and Tenofovir
Started: 9/4/2016